[Amphotericin B channel conductance inactivation].
Effects induced in bilayer lipid membranes by amphotericin B and its alkyl derivatives was analysed. Inactivation of the antibiotic-dependent multichannel membrane conductance was discovered. Kinetics of membrane conductivity was shown to depend on the antibiotic concentration in the membrane. At concentrations between 10(-8) and 10(-7) M, the resulting conductance appeared to the transient. We suggest that the phenomenon of biphasic kinetics of membrane conductance is the result of a consecutive transformation of polyene channels in the membrane: half-pores are assembled on either side of membrane-nonconducting 1; two half-pores combine to build up a conducting channels-conducting 2, and the conducting channels are disassemled to monomers and nonconducting self-associated forms inside the membrane-disassembled state (nonconducting 3). To explain the transient characteristics of the induced conductance, it is proposed that the antibiotic, present in the solution under self-associated form, binds the membrane and forms pores, then dissociates in the bilayer in a non-active monomeric form. The existence of definite monomers and nonconducting self-associated forms of amphotericin B molecules inside the membrane was estimated from the dependence of kinetic conductance of lipid membranes of amphotericin B and its alkyl derivatives, when the antibiotics are washed out from aqueous medium. Equilibrium between different antibiotic assemblies inside the membrane was demonstrated by the kinetics of conductance decrease following washing the antibiotic. Using circular dichroism measurements, we observed that amphotericin B alkyl derivatives were in self-associated form being susceptible to form pores across cholesterol-containing membranes. The phenomenon of biophasic kinetics was observed only in the cholesterol-containing membrane. The substitution of membrane cholesterol for ergosterol provides monotonic kinetics of membrane conductance at any antibiotic concentration.
Ibragimova
V Kh
VKh
Institute of Radiation Problems, National Academy of Sciences of Azerbaijan Republic, Baku.
Alieva
I N
IN
Aliev
D I
DI
D000666:Amphotericin B / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002784:Cholesterol / Q000737:chemistry; D002942:Circular Dichroism; D004305:Dose-Response Relationship, Drug; D004553:Electric Conductivity; D004875:Ergosterol / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism; D008563:Membrane Lipids / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D008566:Membranes / Q000737:chemistry / Q000378:metabolism*; D010743:Phospholipids / Q000737:chemistry; D011189:Potassium Chloride / Q000494:pharmacology; D012996:Solutions; D013329:Structure-Activity Relationship; D013997:Time Factors; D014867:Water / Q000737:chemistry
D000900:Anti-Bacterial Agents; D007473:Ion Channels; D008051:Lipid Bilayers; D008563:Membrane Lipids; D010743:Phospholipids; D012996:Solutions; D014867:Water; C017501:methylamphotericin B; D011189:Potassium Chloride; D000666:Amphotericin B; D002784:Cholesterol; D004875:Ergosterol